Journal of Alzheimer's Research and Therapy

Aims and Scope

Journal of Alzheimer's Research and Therapy (JALR) is dedicated to advancing the understanding and treatment of Alzheimer's disease through the publication of groundbreaking research and innovative content. Our journal scope encompasses a wide range of topics related to Alzheimer's disease, including basic biology, epidemiology, biostatistics, treatment, prevention, and management.
 

JALR welcomes submissions of substantial original research articles, review articles, case reports, and clinical studies that contribute to the advancement of Alzheimer's research and welcomes submissions that integrate artificial intelligence (AI) into Alzheimer’s disease research and clinical practice. 
 

The aims of JALR are as follows:

• Facilitate Exchange of Ideas: JALR provides a platform for the exchange of ideas and collaboration among scientists, clinicians, and healthcare providers in the field of Alzheimer's disease.
• Promote Research: JALR aims to promote research in all aspects of Alzheimer's disease, including diagnosis, prevention, treatment, and management, with a focus on innovative and cutting-edge approaches.
• Comprehensive Overview: JALR seeks to provide a comprehensive overview of current research, practice, and management of patients with Alzheimer's disease, encompassing both basic science and clinical research.
• Knowledge Transfer: JALR aims to facilitate the transfer of knowledge among scientists, clinicians, and healthcare providers in the field of Alzheimer's disease, fostering a culture of continuous learning and improvement.
   

The field of JALR is vast as:

• Pathology and Pathophysiology 
• Diagnosis and Prognosis 
• Clinical Aspects of Alzheimer's Disease 
• Neuropsychiatry and Neurodegeneration 
• Neuroimaging and Neuropsychology 
• Neurochemistry and Neuropharmacology 
• Molecular Genetics, Genomics, and Proteomics 
• Therapeutic Strategies 
• Clinical Trials 
• Social and Psychological Aspects 
• Primary progressive aphasia (PPA)
• Senile dementia
• Palliative care
• Memory
• Lifestyle
• Alzheimer's disease
• Clinical depression
• Lewy body dementia
• Apraxia
• Etiology
• Atrophy
• Diet
• Neurology
• Genetics
• Vascular dementia
• Biochemistry
• Gene Therapy
• Traumatic brain injury
• Medication
• Neurological disorders
• Agnosia
• Frontotemporal dementia
• Clinical trials
• Medications
• Antioxidant
• Memory loss
• Anatomical
• Parkinsonism
• Anomia
• Amyloid
• Mild cognitive impairment
• Neurodegenerative disease
• Dementia with Lewy bodies
• Forgetfulness
• Disorientation
• Amyloid plaques
• Environmental Factors
• Movement Disorder
• Neuropathology
• Neurofibrillary tangles
• Alzheimer's dementia
• Cognitive dysfunction
• Amnestic
• Estrogen replacement therapy
• Early Dementia
• Synaptic plasticity
• Cholinesterase inhibitor
• Brain disorder
• Translational
• Mixed dementia
• Advanced Dementia
• Moderate Dementia
• Alzheimer's care
• Neurodegenerative Disorder
• Managing dementia